Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Orphan_drug> ?p ?o. }
Showing items 1 to 50 of
50
with 100 items per page.
- Orphan_drug abstract "An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease. In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.".
- Orphan_drug wikiPageExternalLink orphreg.htm.
- Orphan_drug wikiPageExternalLink rare_6_en.htm.
- Orphan_drug wikiPageExternalLink www.diahome.org.
- Orphan_drug wikiPageExternalLink FindEducationalOffering.aspx?productID=23774&eventType=Meeting.
- Orphan_drug wikiPageExternalLink default.htm.
- Orphan_drug wikiPageExternalLink ucm119477.htm.
- Orphan_drug wikiPageID "395889".
- Orphan_drug wikiPageRevisionID "604908337".
- Orphan_drug hasPhotoCollection Orphan_drug.
- Orphan_drug subject Category:Biotechnology_law.
- Orphan_drug subject Category:Drug_discovery.
- Orphan_drug subject Category:Health_economics.
- Orphan_drug subject Category:Orphan_drugs.
- Orphan_drug subject Category:Pharmaceuticals_policy.
- Orphan_drug type Agent114778436.
- Orphan_drug type CausalAgent100007347.
- Orphan_drug type Drug103247620.
- Orphan_drug type Matter100020827.
- Orphan_drug type OrphanDrugs.
- Orphan_drug type PhysicalEntity100001930.
- Orphan_drug type Substance100020090.
- Orphan_drug comment "An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease. In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive.".
- Orphan_drug label "Farmaci orfani".
- Orphan_drug label "Leki sieroce".
- Orphan_drug label "Medicamento huérfano".
- Orphan_drug label "Medicamento órfão".
- Orphan_drug label "Médicament orphelin".
- Orphan_drug label "Orphan drug".
- Orphan_drug label "Orphan-Arzneimittel".
- Orphan_drug label "Weesgeneesmiddel".
- Orphan_drug label "Орфанные препараты".
- Orphan_drug label "دواء يتيم".
- Orphan_drug label "孤儿药".
- Orphan_drug label "希少疾病用医薬品".
- Orphan_drug sameAs Orphan-Arzneimittel.
- Orphan_drug sameAs Ορφανό_φάρμακο.
- Orphan_drug sameAs Medicamento_huérfano.
- Orphan_drug sameAs Médicament_orphelin.
- Orphan_drug sameAs Farmaci_orfani.
- Orphan_drug sameAs 希少疾病用医薬品.
- Orphan_drug sameAs Weesgeneesmiddel.
- Orphan_drug sameAs Leki_sieroce.
- Orphan_drug sameAs Medicamento_órfão.
- Orphan_drug sameAs m.02390c.
- Orphan_drug sameAs Q1367466.
- Orphan_drug sameAs Q1367466.
- Orphan_drug sameAs Orphan_drug.
- Orphan_drug wasDerivedFrom Orphan_drug?oldid=604908337.
- Orphan_drug isPrimaryTopicOf Orphan_drug.